SUGAMMADEX

SUGAMMADEX was reported 2731 times

SUGAMMADEX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RECURRENCE OF NEUROMUSCULAR BLOCKADE 107 0.6257
1 TIDAL VOLUME ABNORMAL 2 0.5000
2 NEGATIVE PRESSURE PULMONARY OEDEMA 43 0.4388
3 UNILATERAL BRONCHOSPASM 2 0.3333
4 LARYNGEAL MASK AIRWAY INSERTION 1 0.3333
5 MESENTERIC TRACTION SYNDROME 1 0.2500
6 MEAN ARTERIAL PRESSURE 1 0.2500
7 CRICOPHARYNGEAL ACHALASIA 1 0.2000
8 NEUROMUSCULAR BLOCKADE REVERSAL 1 0.2000
9 ANAESTHESIA REVERSAL 1 0.1667
10 NEUROMUSCULAR BLOCK PROLONGED 53 0.1436
11 TIDAL VOLUME DECREASED 5 0.1282
12 ISCHAEMIC DEMYELINATION 1 0.1250
13 PREMATURE RECOVERY FROM ANAESTHESIA 4 0.1111
14 EXTERNAL HYDROCEPHALUS 1 0.1000
15 POSTRESUSCITATION ENCEPHALOPATHY 5 0.0781
16 AIRWAY PEAK PRESSURE INCREASED 10 0.0658
17 INTERSTITIAL LUNG THICKENING 1 0.0625
18 NEUROMUSCULAR BLOCKING THERAPY 2 0.0606
19 CENTRAL VENOUS PRESSURE DECREASED 2 0.0571
20 AIRWAY COMPLICATION OF ANAESTHESIA 15 0.0570
21 ALVEOLAR-ARTERIAL OXYGEN GRADIENT INCREASED 1 0.0526
22 MAST CELL DEGRANULATION PRESENT 1 0.0526
23 BRONCHITIS CHEMICAL 1 0.0500
24 AGITATION POSTOPERATIVE 3 0.0476
25 ACQUIRED C1 INHIBITOR DEFICIENCY 1 0.0476
26 POSTOPERATIVE RESPIRATORY DISTRESS 3 0.0469
27 ANAESTHETIC COMPLICATION PULMONARY 4 0.0449
28 SUBCAPSULAR SPLENIC HAEMATOMA 2 0.0444
29 END-TIDAL CO2 INCREASED 2 0.0435
30 DELAYED RECOVERY FROM ANAESTHESIA 33 0.0348
31 ENDOCARDIAL DISEASE 1 0.0345
32 VOCAL CORD DYSFUNCTION 17 0.0345
33 EXPOSURE KERATITIS 1 0.0333
34 DEVICE EFFECT INCOMPLETE 1 0.0312
35 CHEST WALL RIGIDITY 2 0.0312
36 PSEUDOCHOLINESTERASE DEFICIENCY 2 0.0308
37 CHANTER SYNDROME 3 0.0300
38 PANCREATIC LEAK 3 0.0268
39 NEUROMUSCULAR BLOCKADE 6 0.0268
40 FEMALE SEX HORMONE LEVEL ABNORMAL 1 0.0227
41 END-TIDAL CO2 DECREASED 1 0.0213
42 POSTOPERATIVE DELIRIUM 4 0.0202
43 GLOSSOPTOSIS 4 0.0183
44 BASELINE FOETAL HEART RATE VARIABILITY DISORDER 1 0.0182
45 DRUG HALF-LIFE INCREASED 2 0.0175
46 KOUNIS SYNDROME 37 0.0163
47 FEMORAL NERVE PALSY 1 0.0156
48 DEAFNESS PERMANENT 3 0.0153
49 LARYNGOSPASM 40 0.0149
50 ANAESTHETIC COMPLICATION CARDIAC 1 0.0145
51 HYSTEROTOMY 1 0.0143
52 PARALYSIS RECURRENT LARYNGEAL NERVE 2 0.0137
53 ENDOTRACHEAL INTUBATION COMPLICATION 8 0.0136
54 DIAPHRAGMATIC INJURY 1 0.0135
55 MECHANICAL VENTILATION COMPLICATION 2 0.0134
56 AUTOPHONY 1 0.0133
57 CARDIAC CONTRACTILITY DECREASED 1 0.0130
58 EXTUBATION 1 0.0123
59 BLADDER STENOSIS 1 0.0122
60 BRONCHOSPASM 173 0.0121
61 MEAN ARTERIAL PRESSURE DECREASED 3 0.0119
62 MITOCHONDRIAL DNA MUTATION 1 0.0116
63 FOETAL HEART RATE INCREASED 1 0.0114
64 HYPOVENTILATION 37 0.0113
65 ANAESTHETIC COMPLICATION NEUROLOGICAL 10 0.0110
66 LARYNGEAL OBSTRUCTION 2 0.0109
67 PSYCHOGENIC SEIZURE 10 0.0107
68 SCROTAL ABSCESS 4 0.0106
69 CONGENITAL PNEUMONIA 1 0.0105
70 PRODUCT BARCODE ISSUE 4 0.0104
71 TRYPTASE INCREASED 7 0.0098
72 EAR DRYNESS 1 0.0095
73 AORTIC INJURY 1 0.0095
74 RESPIRATORY TRACT OEDEMA 7 0.0094
75 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 3 0.0093
76 PHRENIC NERVE PARALYSIS 2 0.0091
77 BREATH SOUNDS ABSENT 1 0.0091
78 MATERNAL EXPOSURE DURING DELIVERY 9 0.0091
79 DRUG EFFECT FASTER THAN EXPECTED 3 0.0090
80 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 1 0.0089
81 HYPERTHERMIA MALIGNANT 13 0.0087
82 LARYNGEAL HAEMORRHAGE 1 0.0087
83 NECROTISING SOFT TISSUE INFECTION 2 0.0087
84 VOCAL CORD PARESIS 2 0.0086
85 ANAPHYLACTOID SHOCK 4 0.0085
86 INCARCERATED INGUINAL HERNIA 1 0.0082
87 ENDOTRACHEAL INTUBATION 23 0.0082
88 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
89 AIRWAY REMODELLING 1 0.0081
90 UPPER AIRWAY OBSTRUCTION 7 0.0079
91 MAGNETIC RESONANCE IMAGING 1 0.0078
92 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 8 0.0073
93 WRONG PRODUCT STORED 2 0.0070
94 HYPOTENSIVE CRISIS 1 0.0069
95 NEONATAL RESPIRATORY ARREST 1 0.0068
96 DERMATOCHALASIS 1 0.0068
97 ANAPHYLACTIC SHOCK 174 0.0067
98 PERINEAL ABSCESS 3 0.0067
99 THERAPEUTIC PRODUCT EFFECT PROLONGED 3 0.0066
100 ABDOMINAL WALL WOUND 1 0.0065
101 DACRYOCYSTITIS 1 0.0065
102 INTRA-ABDOMINAL PRESSURE INCREASED 1 0.0064
103 INTENSIVE CARE 9 0.0063
104 ANTICHOLINERGIC SYNDROME 10 0.0063
105 CONFUSIONAL AROUSAL 1 0.0062
106 DYSCHROMATOPSIA 5 0.0060
107 PULSELESS ELECTRICAL ACTIVITY 25 0.0060
108 DIASTOLIC HYPOTENSION 1 0.0059
109 TRACHEAL STENOSIS 3 0.0059
110 CLONUS 16 0.0058
111 INSTILLATION SITE SWELLING 1 0.0057
112 ANAPHYLACTIC REACTION 315 0.0057
113 CORONARY ARTERY INSUFFICIENCY 2 0.0056
114 BRADYCARDIA 285 0.0054
115 INJECTION SITE ECZEMA 1 0.0052
116 MYASTHENIC SYNDROME 4 0.0052
117 THERAPEUTIC PRODUCT EFFECT INCREASED 6 0.0052
118 BREAST FEEDING 4 0.0051
119 DOSE CALCULATION ERROR 3 0.0051
120 SINUS ARREST 8 0.0051
121 EOSINOPHIL PERCENTAGE DECREASED 1 0.0050
122 PRINZMETAL ANGINA 5 0.0050
123 DIAPHRAGMATIC PARALYSIS 3 0.0050
124 GENITAL ABSCESS 2 0.0050
125 BRADYCARDIA FOETAL 4 0.0048
126 INFLUENZA VIRUS TEST POSITIVE 1 0.0047
127 OROPHARYNGEAL SPASM 2 0.0047
128 PROCEDURAL HYPOTENSION 4 0.0047
129 IMMOBILISATION SYNDROME 1 0.0047
130 MUSCLE OEDEMA 1 0.0046
131 HYPERREFLEXIA 16 0.0046
132 DEAFNESS NEUROSENSORY 15 0.0046
133 STRIDOR 13 0.0044
134 INFUSION SITE PHLEBITIS 1 0.0044
135 CONTINUOUS POSITIVE AIRWAY PRESSURE 1 0.0043
136 HYPOGONADISM MALE 1 0.0043
137 BRONCHOSCOPY 1 0.0042
138 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 11 0.0042
139 BODY MASS INDEX ABNORMAL 1 0.0041
140 ELECTROCARDIOGRAM P WAVE ABNORMAL 1 0.0041
141 RESPIRATORY ACIDOSIS 16 0.0041
142 NEONATAL SEIZURE 1 0.0040
143 ARTERIOSPASM CORONARY 16 0.0040
144 BETA 2 MICROGLOBULIN INCREASED 1 0.0038
145 EPIGLOTTIC OEDEMA 1 0.0038
146 CYTOTOXIC OEDEMA 1 0.0038
147 PRIAPISM 13 0.0038
148 ANAESTHETIC COMPLICATION 10 0.0037
149 MECHANICAL VENTILATION 7 0.0037
150 HYPERCAPNIA 11 0.0036
151 BRADYARRHYTHMIA 6 0.0036
152 COR PULMONALE ACUTE 1 0.0036
153 CONTRAINDICATED DRUG PRESCRIBED 1 0.0035
154 EUSTACHIAN TUBE DYSFUNCTION 2 0.0035
155 EOSINOPHILIC PNEUMONIA ACUTE 3 0.0035
156 NERVE BLOCK 2 0.0034
157 CARDIAC PROCEDURE COMPLICATION 2 0.0033
158 PRODUCT APPEARANCE CONFUSION 3 0.0032
159 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 7 0.0032
160 STOMA SITE HYPERGRANULATION 2 0.0032
161 CHOLINERGIC SYNDROME 2 0.0031
162 EXTRAOCULAR MUSCLE DISORDER 1 0.0031
163 ADMINISTRATION SITE SWELLING 1 0.0031
164 SUBCUTANEOUS EMPHYSEMA 3 0.0031
165 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
166 COAGULATION TIME SHORTENED 1 0.0030
167 BENIGN NEOPLASM OF SKIN 1 0.0030
168 ENTEROSTOMY 1 0.0029
169 CUBITAL TUNNEL SYNDROME 1 0.0029
170 GAS GANGRENE 1 0.0029
171 ANAPHYLACTOID REACTION 12 0.0029
172 CHOREA 5 0.0029
173 CONSCIOUSNESS FLUCTUATING 3 0.0029
174 MUSCLE HYPERTROPHY 1 0.0028
175 OCULOGYRIC CRISIS 6 0.0028
176 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17 0.0028
177 CEREBRAL MASS EFFECT 1 0.0028
178 HAEMODYNAMIC INSTABILITY 21 0.0028
179 CANCER PAIN 7 0.0027
180 DRUG-DISEASE INTERACTION 2 0.0027
181 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 9 0.0027
182 PERIRECTAL ABSCESS 3 0.0027
183 APNOEA 21 0.0027
184 BRAIN STEM SYNDROME 2 0.0027
185 NASAL TURBINATE HYPERTROPHY 1 0.0027
186 ANISOCORIA 1 0.0026
187 LARYNGEAL OEDEMA 16 0.0026
188 INTRACRANIAL TUMOUR HAEMORRHAGE 1 0.0026
189 HAEMOPERITONEUM 2 0.0025
190 ELECTROCARDIOGRAM T WAVE PEAKED 1 0.0025
191 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
192 RESUSCITATION 4 0.0024
193 CARDIAC ARREST 195 0.0024
194 GAZE PALSY 4 0.0023
195 FRONTOTEMPORAL DEMENTIA 1 0.0023
196 ENDOCRINE OPHTHALMOPATHY 2 0.0023
197 CONGENITAL MUSCULOSKELETAL ANOMALY 1 0.0023
198 MUSCLE ENZYME INCREASED 1 0.0023
199 VENTRICULAR FIBRILLATION 25 0.0022
200 POSTPARTUM HAEMORRHAGE 3 0.0022
201 VASOSPASM 2 0.0022
202 LOCKED-IN SYNDROME 1 0.0022
203 CEREBRAL HYPOPERFUSION 1 0.0021
204 MAST CELL ACTIVATION SYNDROME 3 0.0021
205 PRODUCT PACKAGING CONFUSION 5 0.0021
206 LENTIGO 1 0.0020
207 BRAIN HYPOXIA 2 0.0020
208 STOMA SITE HAEMORRHAGE 3 0.0019
209 CONJUNCTIVAL OEDEMA 2 0.0019
210 ATRIOVENTRICULAR BLOCK COMPLETE 13 0.0019
211 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 15 0.0019
212 COGWHEEL RIGIDITY 2 0.0019
213 HYPOXIA 67 0.0019
214 PARADOXICAL DRUG REACTION 7 0.0019
215 FRACTURE OF PENIS 1 0.0019
216 PULSE ABSENT 9 0.0019
217 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 2 0.0019
218 ASTERIXIS 2 0.0019
219 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
220 ANAL ATRESIA 1 0.0019
221 LANGUAGE DISORDER 4 0.0018
222 MACROGLOSSIA 1 0.0018
223 NEUROLOGIC NEGLECT SYNDROME 1 0.0018
224 CHOLESTATIC LIVER INJURY 4 0.0018
225 BONE FRAGMENTATION 1 0.0018
226 ACUTE PULMONARY OEDEMA 10 0.0018
227 MEDICAL DEVICE SITE PAIN 1 0.0018
228 PAROTITIS 2 0.0017
229 RESPIRATORY ARREST 47 0.0017
230 GROIN ABSCESS 2 0.0017
231 MUSCLE TWITCHING 39 0.0017
232 TACHYPNOEA 23 0.0017
233 OXYGEN SATURATION DECREASED 95 0.0017
234 LYMPHATIC DISORDER 1 0.0017
235 VOCAL CORD PARALYSIS 3 0.0017
236 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
237 BRONCHIAL HYPERREACTIVITY 2 0.0017
238 FAT NECROSIS 1 0.0016
239 RESPIRATORY DEPRESSION 20 0.0016
240 PARALYSIS 23 0.0016
241 PULMONARY ALVEOLAR HAEMORRHAGE 9 0.0016
242 FOETAL HEART RATE DECREASED 1 0.0016
243 DERMATOSIS 1 0.0016
244 HYPERAESTHESIA 13 0.0016
245 EXTREMITY CONTRACTURE 1 0.0016
246 CYANOSIS NEONATAL 1 0.0016
247 ABDOMINAL WALL ABSCESS 1 0.0015
248 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
249 COMPARTMENT SYNDROME 4 0.0015
250 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
251 DIPLEGIA 3 0.0015
252 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
253 LYMPHOCELE 1 0.0015
254 CATARACT NUCLEAR 1 0.0015
255 CARBON DIOXIDE INCREASED 2 0.0015
256 FEELING OF RELAXATION 1 0.0015
257 HEAD TITUBATION 2 0.0015
258 RHONCHI 2 0.0014
259 CRANIAL NERVE DISORDER 1 0.0014
260 LIP OEDEMA 6 0.0014
261 CERVICAL RADICULOPATHY 1 0.0014
262 SPUTUM INCREASED 3 0.0014
263 DISSOCIATIVE DISORDER 1 0.0014
264 CEREBELLAR SYNDROME 3 0.0014
265 NODAL RHYTHM 2 0.0014
266 CLONIC CONVULSION 1 0.0014
267 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
268 CEREBRAL VASOCONSTRICTION 1 0.0014
269 BRAIN HERNIATION 4 0.0013
270 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
271 CAUDA EQUINA SYNDROME 1 0.0013
272 HYPOTONIA 13 0.0013
273 ATRIOVENTRICULAR BLOCK 10 0.0013
274 INFUSION SITE EXTRAVASATION 8 0.0013
275 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 33 0.0013
276 INHIBITORY DRUG INTERACTION 2 0.0013
277 VENTRICULAR HYPOKINESIA 4 0.0012
278 MATERNAL EXPOSURE DURING BREAST FEEDING 5 0.0012
279 GENERALISED ERYTHEMA 7 0.0012
280 PULMONARY ARTERIAL PRESSURE INCREASED 2 0.0012
281 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
282 MEDICAL PROCEDURE 2 0.0012
283 TACHYARRHYTHMIA 3 0.0012
284 PRODUCT LABEL CONFUSION 7 0.0012
285 MEAN PLATELET VOLUME DECREASED 1 0.0012
286 SEDATION COMPLICATION 3 0.0012
287 INCREASED BRONCHIAL SECRETION 3 0.0012
288 BLOOD PH DECREASED 2 0.0012
289 TYPE I HYPERSENSITIVITY 4 0.0011
290 NECROTISING FASCIITIS 4 0.0011
291 PHYSICAL DISABILITY 5 0.0011
292 BRADYPNOEA 3 0.0011
293 HYDROCEPHALUS 6 0.0011
294 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
295 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
296 SEROTONIN SYNDROME 21 0.0011
297 CERUMEN IMPACTION 1 0.0011
298 ANGIOEDEMA 47 0.0011
299 NEONATAL RESPIRATORY DISTRESS 1 0.0011
300 CIRCULATORY COLLAPSE 18 0.0011
301 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
302 ELECTROCARDIOGRAM CHANGE 1 0.0011
303 ARNOLD-CHIARI MALFORMATION 1 0.0010
304 COMA SCALE ABNORMAL 3 0.0010
305 ADENOVIRUS INFECTION 3 0.0010
306 STRESS CARDIOMYOPATHY 6 0.0010
307 VENTRICULAR TACHYCARDIA 17 0.0010
308 ABDOMINAL WALL HAEMATOMA 2 0.0010
309 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
310 MASTOIDITIS 1 0.0010
311 DUODENAL PERFORATION 1 0.0010
312 VOCAL CORD DISORDER 2 0.0010
313 BLOOD ALBUMIN DECREASED 8 0.0010
314 BLOOD PRESSURE DECREASED 67 0.0010
315 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
316 OBSTRUCTIVE AIRWAYS DISORDER 11 0.0010
317 HYPERTENSIVE CRISIS 11 0.0010
318 DRUG EXPOSURE BEFORE PREGNANCY 1 0.0010
319 TOXIC ENCEPHALOPATHY 5 0.0010
320 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
321 TRISMUS 5 0.0010
322 BRUGADA SYNDROME 1 0.0010
323 LIVEDO RETICULARIS 2 0.0010
324 METASTASES TO PLEURA 1 0.0010
325 FACTOR VIII INHIBITION 1 0.0010
326 BONE DEMINERALISATION 1 0.0009
327 NEUROMYOPATHY 1 0.0009
328 HYPERTENSIVE NEPHROPATHY 1 0.0009
329 BLADDER DILATATION 1 0.0009
330 PROCEDURAL COMPLICATION 7 0.0009
331 ENDOMETRIAL CANCER 2 0.0009
332 NEPHROSCLEROSIS 1 0.0009
333 CRYPTORCHISM 1 0.0009
334 WRONG PRODUCT ADMINISTERED 6 0.0009
335 DRUG EFFECT DELAYED 4 0.0009
336 CARDIOMYOPATHY 13 0.0009
337 ARTERIAL HAEMORRHAGE 1 0.0009
338 HYPOPNOEA 3 0.0009
339 LUMBAR RADICULOPATHY 1 0.0009
340 EYELID OEDEMA 10 0.0009
341 POST PROCEDURAL HAEMORRHAGE 10 0.0009
342 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0009
343 LABILE BLOOD PRESSURE 1 0.0008
344 NEUTROPENIC SEPSIS 6 0.0008
345 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0008
346 MUSCLE RIGIDITY 10 0.0008
347 HAEMATOMA MUSCLE 1 0.0008
348 PULSE ABNORMAL 2 0.0008
349 CYANOSIS 13 0.0008
350 SHOCK 19 0.0008
351 HYPOTENSION 165 0.0008
352 VENTRICULAR ARRHYTHMIA 3 0.0008
353 EYE OEDEMA 2 0.0008
354 MALIGNANT MELANOMA IN SITU 1 0.0008
355 HYPERPARATHYROIDISM SECONDARY 2 0.0008
356 VASODILATATION 2 0.0008
357 HYPOTHERMIA 8 0.0008
358 TONGUE OEDEMA 3 0.0008
359 BODY TEMPERATURE INCREASED 16 0.0008
360 BILIARY OBSTRUCTION 1 0.0008
361 POSTMENOPAUSAL HAEMORRHAGE 2 0.0008
362 DRUG CLEARANCE DECREASED 1 0.0008
363 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
364 EXTRADURAL HAEMATOMA 1 0.0008
365 LOW BIRTH WEIGHT BABY 6 0.0008
366 HYPERLACTACIDAEMIA 2 0.0007
367 RESPIRATORY DISTRESS 20 0.0007
368 SINUS BRADYCARDIA 7 0.0007
369 HEART RATE ABNORMAL 4 0.0007
370 EXTRASYSTOLES 5 0.0007
371 LUNG CONSOLIDATION 2 0.0007
372 THERAPEUTIC RESPONSE DELAYED 2 0.0007
373 BRONCHIAL OBSTRUCTION 1 0.0007
374 ALVEOLITIS 1 0.0007
375 FANCONI SYNDROME 1 0.0007
376 AUDITORY DISORDER 1 0.0007
377 OXYGEN SATURATION ABNORMAL 2 0.0007
378 ABSCESS LIMB 3 0.0007
379 CARDIO-RESPIRATORY ARREST 29 0.0007
380 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
381 STRABISMUS 2 0.0007
382 APRAXIA 1 0.0007
383 MYASTHENIA GRAVIS CRISIS 1 0.0007
384 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
385 VENTRICULAR EXTRASYSTOLES 7 0.0007
386 ILEUS PARALYTIC 3 0.0007
387 RESPIRATORY FAILURE 49 0.0007
388 PULMONARY OEDEMA 30 0.0007
389 PALLOR 18 0.0007
390 DAYDREAMING 1 0.0006
391 MEAN CELL VOLUME DECREASED 1 0.0006
392 NEPHROGENIC ANAEMIA 3 0.0006
393 BRAIN DEATH 2 0.0006
394 TACHYCARDIA 57 0.0006
395 HYPOTONIA NEONATAL 1 0.0006
396 RESPIRATORY RATE DECREASED 2 0.0006
397 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
398 SPUTUM DISCOLOURED 6 0.0006
399 SCREAMING 4 0.0006
400 UNRESPONSIVE TO STIMULI 16 0.0006
401 HYPOGLYCAEMIA NEONATAL 1 0.0006
402 MATERNAL EXPOSURE DURING PREGNANCY 55 0.0006
403 LIVER ABSCESS 2 0.0006
404 OEDEMA MOUTH 2 0.0006
405 INJECTION RELATED REACTION 1 0.0006
406 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
407 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
408 PRODUCT PRESCRIBING ISSUE 13 0.0006
409 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
410 WOUND COMPLICATION 2 0.0006
411 MILIARIA 1 0.0006
412 HYPOPITUITARISM 1 0.0006
413 HEART RATE DECREASED 20 0.0006
414 PNEUMOTHORAX 9 0.0006
415 IMPRISONMENT 1 0.0006
416 MITRAL VALVE DISEASE 1 0.0006
417 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
418 ANAL ABSCESS 3 0.0006
419 ESSENTIAL HYPERTENSION 1 0.0005
420 BODY TEMPERATURE ABNORMAL 1 0.0005
421 DYSKINESIA 22 0.0005
422 CHRONIC SINUSITIS 2 0.0005
423 CHOLECYSTITIS ACUTE 3 0.0005
424 JAUNDICE NEONATAL 1 0.0005
425 GUN SHOT WOUND 1 0.0005
426 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
427 ACUTE RESPIRATORY FAILURE 10 0.0005
428 RALES 3 0.0005
429 CONVERSION DISORDER 1 0.0005
430 EARLY SATIETY 1 0.0005
431 HYPOVOLAEMIA 3 0.0005
432 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
433 NASAL SEPTUM DEVIATION 1 0.0005
434 MULTI-ORGAN DISORDER 1 0.0005
435 HYPERAEMIA 1 0.0005
436 DEPRESSED LEVEL OF CONSCIOUSNESS 20 0.0005
437 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
438 BRAIN INJURY 5 0.0005
439 DRUG EFFECT INCOMPLETE 18 0.0005
440 FOAMING AT MOUTH 1 0.0005
441 RASH MACULO-PAPULAR 11 0.0005
442 EAR HAEMORRHAGE 1 0.0005
443 MUSCLE CONTRACTURE 1 0.0005
444 DRUG INTERACTION 78 0.0005
445 SHOCK HAEMORRHAGIC 4 0.0005
446 EXTRAVASATION 2 0.0005
447 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
448 DIVERTICULAR PERFORATION 1 0.0005
449 CHEST INJURY 1 0.0005
450 BODY TEMPERATURE FLUCTUATION 1 0.0005
451 PETECHIAE 5 0.0005
452 LUNG ABSCESS 1 0.0005
453 FACE OEDEMA 8 0.0005
454 FOETAL DISTRESS SYNDROME 1 0.0005
455 POOR PERIPHERAL CIRCULATION 2 0.0005
456 PRODUCT CONTAINER ISSUE 4 0.0005
457 ABSCESS INTESTINAL 1 0.0005
458 INFUSION SITE BRUISING 1 0.0005
459 MIDDLE EAR EFFUSION 1 0.0005
460 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
461 ADENOCARCINOMA 1 0.0004
462 CHRONIC GASTRITIS 1 0.0004
463 DISTRIBUTIVE SHOCK 1 0.0004
464 RESPIRATION ABNORMAL 3 0.0004
465 EYELID DISORDER 1 0.0004
466 HAEMANGIOMA 1 0.0004
467 SKIN ABRASION 2 0.0004
468 SINUS TACHYCARDIA 6 0.0004
469 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
470 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
471 CHOLECYSTITIS 5 0.0004
472 SUBCUTANEOUS ABSCESS 2 0.0004
473 GRAFT VERSUS HOST DISEASE 3 0.0004
474 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
475 BLINDNESS TRANSIENT 3 0.0004
476 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
477 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
478 RESPIRATORY DISORDER 12 0.0004
479 CORONARY ARTERY STENOSIS 2 0.0004
480 ECONOMIC PROBLEM 6 0.0004
481 ACIDOSIS 3 0.0004
482 ANGLE CLOSURE GLAUCOMA 1 0.0004
483 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
484 MYDRIASIS 5 0.0004
485 MEAN CELL VOLUME INCREASED 1 0.0004
486 FOETAL DEATH 2 0.0004
487 HERNIA REPAIR 1 0.0004
488 CATATONIA 2 0.0004
489 LUNG OPACITY 1 0.0004
490 DELIRIUM 13 0.0004
491 MOVEMENT DISORDER 12 0.0004
492 BREAST SWELLING 1 0.0004
493 MYASTHENIA GRAVIS 3 0.0004
494 OEDEMA 20 0.0004
495 ABDOMINAL RIGIDITY 1 0.0004
496 ASPIRATION 4 0.0004
497 CHOLECYSTITIS INFECTIVE 1 0.0004
498 DRUG TOLERANCE DECREASED 1 0.0004
499 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
500 SKIN REACTION 5 0.0004
501 PERIORBITAL SWELLING 2 0.0004
502 HYPERTONIC BLADDER 1 0.0003
503 ABORTION 1 0.0003
504 HEPATITIS FULMINANT 1 0.0003
505 CREPITATIONS 1 0.0003
506 MYOCLONUS 4 0.0003
507 METABOLIC ENCEPHALOPATHY 1 0.0003
508 HIV INFECTION 1 0.0003
509 CENTRAL VENOUS CATHETERISATION 1 0.0003
510 FOETAL GROWTH RESTRICTION 2 0.0003
511 ENCEPHALOPATHY 8 0.0003
512 ECTOPIC PREGNANCY 1 0.0003
513 CHOLANGITIS 2 0.0003
514 ILEUS 4 0.0003
515 DRUG EFFECT INCREASED 1 0.0003
516 BLADDER PAIN 1 0.0003
517 PREMATURE DELIVERY 5 0.0003
518 RASH PRURITIC 17 0.0003
519 AGITATION 23 0.0003
520 URTICARIA 52 0.0003
521 THROMBOTIC MICROANGIOPATHY 3 0.0003
522 SALIVARY HYPERSECRETION 3 0.0003
523 EYE MOVEMENT DISORDER 2 0.0003
524 ECCHYMOSIS 2 0.0003
525 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
526 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
527 MICTURITION DISORDER 1 0.0003
528 SWOLLEN TONGUE 9 0.0003
529 LOGORRHOEA 1 0.0003
530 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
531 FACIAL PARESIS 1 0.0003
532 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
533 METABOLIC ACIDOSIS 9 0.0003
534 HAEMORRHAGIC DIATHESIS 1 0.0003
535 CONJUNCTIVAL HYPERAEMIA 1 0.0003
536 APPENDICECTOMY 1 0.0003
537 IMPAIRED QUALITY OF LIFE 4 0.0003
538 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
539 FACIAL BONES FRACTURE 1 0.0003
540 APPARENT DEATH 1 0.0003
541 MONOCYTE COUNT INCREASED 1 0.0003
542 ASTHMATIC CRISIS 1 0.0003
543 INTENTIONAL UNDERDOSE 2 0.0003
544 FOOD INTOLERANCE 1 0.0003
545 EXTRA DOSE ADMINISTERED 11 0.0003
546 AMYLASE INCREASED 1 0.0003
547 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
548 MUCOSAL INFLAMMATION 7 0.0003
549 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
550 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
551 AUTOIMMUNE THYROIDITIS 1 0.0003
552 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
553 POST PROCEDURAL COMPLICATION 5 0.0003
554 PHARYNGEAL OEDEMA 4 0.0003
555 DYSTONIA 5 0.0003
556 EPIGASTRIC DISCOMFORT 1 0.0003
557 PULMONARY HAEMORRHAGE 2 0.0003
558 ARRHYTHMIA 12 0.0003
559 DISABILITY 5 0.0003
560 WOUND 7 0.0003
561 GALLBLADDER OPERATION 1 0.0002
562 UNDERDOSE 18 0.0002
563 ASPHYXIA 2 0.0002
564 THERAPY NON-RESPONDER 11 0.0002
565 DEMYELINATION 1 0.0002
566 ARTHRITIS BACTERIAL 1 0.0002
567 INJECTION SITE EXTRAVASATION 3 0.0002
568 ACUTE CORONARY SYNDROME 2 0.0002
569 MUSCLE INJURY 2 0.0002
570 EOSINOPHIL COUNT INCREASED 2 0.0002
571 ERYTHEMA 49 0.0002
572 BRAIN OEDEMA 3 0.0002
573 HYPERPYREXIA 1 0.0002
574 WHEEZING 14 0.0002
575 MUSCLE FATIGUE 1 0.0002
576 AORTIC VALVE INCOMPETENCE 1 0.0002
577 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
578 LIVER FUNCTION TEST INCREASED 5 0.0002
579 RASH GENERALISED 6 0.0002
580 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
581 MELANOCYTIC NAEVUS 1 0.0002
582 TUMOUR LYSIS SYNDROME 2 0.0002
583 PRODUCT COMMUNICATION ISSUE 2 0.0002
584 LUNG INFILTRATION 2 0.0002
585 ABDOMINAL ABSCESS 1 0.0002
586 DRUG ERUPTION 4 0.0002
587 WRONG DRUG ADMINISTERED 2 0.0002
588 CEREBRAL HAEMORRHAGE 8 0.0002
589 LEUKOCYTOSIS 4 0.0002
590 NO ADVERSE EVENT 40 0.0002
591 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
592 C-REACTIVE PROTEIN INCREASED 8 0.0002
593 END STAGE RENAL DISEASE 4 0.0002
594 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
595 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
596 EYE OPERATION 1 0.0002
597 UROSEPSIS 2 0.0002
598 LOCALISED OEDEMA 1 0.0002
599 INTERCEPTED MEDICATION ERROR 1 0.0002
600 HAEMOPTYSIS 6 0.0002
601 APPENDICITIS 2 0.0002
602 CARDIAC TAMPONADE 1 0.0002
603 SPEECH DISORDER 11 0.0002
604 PARAESTHESIA ORAL 3 0.0002
605 PRODUCT USE ISSUE 39 0.0002
606 SEPTIC SHOCK 9 0.0002
607 HORMONE LEVEL ABNORMAL 1 0.0002
608 BODY TEMPERATURE DECREASED 2 0.0002
609 BREATH SOUNDS ABNORMAL 1 0.0002
610 EXTRAPYRAMIDAL DISORDER 5 0.0002
611 HYPERNATRAEMIA 1 0.0002
612 HEPATIC ENZYME ABNORMAL 1 0.0002
613 OVARIAN CYST 2 0.0002
614 SWELLING FACE 13 0.0002
615 PREMATURE BABY 6 0.0002
616 HYPOAESTHESIA ORAL 3 0.0002
617 EPILEPSY 6 0.0002
618 ADVERSE EVENT 18 0.0002
619 NEUTROPHIL COUNT INCREASED 2 0.0002
620 EAR DISCOMFORT 2 0.0002
621 CEREBRAL ISCHAEMIA 1 0.0002
622 PRODUCT USE IN UNAPPROVED INDICATION 48 0.0002
623 EXPOSURE DURING PREGNANCY 12 0.0002
624 HAEMATOMA 5 0.0002
625 APLASTIC ANAEMIA 1 0.0002
626 UNINTENDED PREGNANCY 2 0.0002
627 DRUG-INDUCED LIVER INJURY 6 0.0002
628 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
629 ANAL FISTULA 1 0.0002
630 LACTIC ACIDOSIS 6 0.0002
631 ERYTHEMA OF EYELID 1 0.0002
632 INTESTINAL ISCHAEMIA 1 0.0002
633 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
634 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
635 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
636 NERVE INJURY 2 0.0002
637 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
638 MITRAL VALVE INCOMPETENCE 2 0.0002
639 NEUTROPHILIA 1 0.0002
640 MYOCARDIAL ISCHAEMIA 2 0.0002
641 HYPERTONIA 1 0.0002
642 ATRIAL FIBRILLATION 17 0.0002
643 ENTEROCOLITIS 1 0.0002
644 HYPERVENTILATION 1 0.0002
645 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
646 METABOLIC DISORDER 1 0.0002
647 SURGERY 10 0.0002
648 COLD SWEAT 3 0.0002
649 LYMPHOCYTE COUNT DECREASED 3 0.0002
650 BRADYKINESIA 1 0.0002
651 BACTERAEMIA 2 0.0002
652 RHABDOMYOLYSIS 7 0.0002
653 HYPERSENSITIVITY 31 0.0002
654 HYPERTENSION 35 0.0002
655 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
656 CRYING 6 0.0002
657 MENTAL IMPAIRMENT 4 0.0002
658 INGUINAL HERNIA 1 0.0002
659 SMALL INTESTINAL OBSTRUCTION 2 0.0002
660 HEPATIC FUNCTION ABNORMAL 6 0.0002
661 PNEUMONIA ASPIRATION 4 0.0002
662 AGGRESSION 8 0.0002
663 BLEPHAROSPASM 1 0.0002
664 HEPATITIS 4 0.0002
665 ENTERITIS 1 0.0002
666 SEIZURE 18 0.0002
667 DRUG RESISTANCE 4 0.0002
668 CHOKING 3 0.0002
669 INCORRECT PRODUCT STORAGE 2 0.0002
670 BLOOD PRESSURE ABNORMAL 3 0.0002
671 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
672 URINARY RETENTION 5 0.0001
673 CYTOKINE RELEASE SYNDROME 3 0.0001
674 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
675 QUALITY OF LIFE DECREASED 2 0.0001
676 PRODUCT ADMINISTRATION ERROR 3 0.0001
677 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
678 PERIPHERAL COLDNESS 2 0.0001
679 HAIR GROWTH ABNORMAL 1 0.0001
680 MENTAL STATUS CHANGES 4 0.0001
681 FEELING COLD 4 0.0001
682 HALLUCINATION, VISUAL 3 0.0001
683 LOSS OF CONSCIOUSNESS 18 0.0001
684 DERMATITIS BULLOUS 1 0.0001
685 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
686 BONE PAIN 8 0.0001
687 INCORRECT DOSE ADMINISTERED 31 0.0001
688 ACUTE MYOCARDIAL INFARCTION 4 0.0001
689 HYDRONEPHROSIS 1 0.0001
690 PARAESTHESIA 21 0.0001
691 MUSCULAR WEAKNESS 15 0.0001
692 OSTEOPENIA 2 0.0001
693 HYPERTHERMIA 1 0.0001
694 TINNITUS 6 0.0001
695 AFFECTIVE DISORDER 1 0.0001
696 DISORIENTATION 5 0.0001
697 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
698 OBESITY 2 0.0001
699 DYSPNOEA 71 0.0001
700 FRUSTRATION TOLERANCE DECREASED 1 0.0001
701 CONFUSIONAL STATE 20 0.0001
702 BLOOD POTASSIUM INCREASED 2 0.0001
703 DECUBITUS ULCER 1 0.0001
704 HICCUPS 1 0.0001
705 RENAL FAILURE 16 0.0001
706 COAGULOPATHY 2 0.0001
707 BLOOD UREA INCREASED 2 0.0001
708 HAEMODIALYSIS 1 0.0001
709 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
710 CARDIOVASCULAR DISORDER 3 0.0001
711 FLUSHING 12 0.0001
712 SEPSIS 13 0.0001
713 MYOPATHY 1 0.0001
714 MULTI-ORGAN FAILURE 2 0.0001
715 HYSTERECTOMY 1 0.0001
716 SEDATION 3 0.0001
717 HYPERKALAEMIA 4 0.0001
718 IMMUNOSUPPRESSION 1 0.0001
719 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
720 THIRST 2 0.0001
721 MYOSITIS 1 0.0001
722 OVERDOSE 24 0.0001
723 DRUG INEFFECTIVE 145 0.0001
724 OFF LABEL USE 96 0.0001
725 RESTLESSNESS 4 0.0001
726 BRAIN NEOPLASM 1 0.0001
727 EYE SWELLING 4 0.0001
728 FLANK PAIN 1 0.0001
729 HYPOCALCAEMIA 2 0.0001
730 RASH 46 0.0001
731 CHRONIC KIDNEY DISEASE 8 0.0001
732 EYE INFLAMMATION 1 0.0001
733 BLOOD PRESSURE INCREASED 16 0.0001
734 CHOLESTASIS 2 0.0001
735 DYSPHONIA 6 0.0001
736 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
737 URINARY INCONTINENCE 3 0.0001
738 INJURY 7 0.0001
739 HEPATIC FAILURE 3 0.0001
740 CELLULITIS 5 0.0001
741 OEDEMA PERIPHERAL 12 0.0001
742 MOTOR DYSFUNCTION 1 0.0001
743 NERVOUS SYSTEM DISORDER 3 0.0001
744 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
745 PRODUCT QUALITY ISSUE 13 0.0001
746 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
747 BREAST PAIN 1 0.0001
748 EPISTAXIS 7 0.0001
749 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
750 AMNESIA 6 0.0001
751 IMPAIRED HEALING 3 0.0001
752 MUSCULOSKELETAL STIFFNESS 8 0.0001
753 DENTAL CARIES 1 0.0001
754 LIP SWELLING 3 0.0001
755 PANCYTOPENIA 5 0.0001
756 HEART RATE IRREGULAR 2 0.0001
757 CHOLECYSTECTOMY 1 0.0001
758 SKIN DISCOLOURATION 4 0.0001
759 NEOPLASM 1 0.0001
760 METASTASES TO LUNG 1 0.0001
761 PERICARDIAL EFFUSION 2 0.0001
762 HYPERHIDROSIS 11 0.0001
763 ACUTE KIDNEY INJURY 13 0.0001
764 ATAXIA 1 0.0001
765 PULMONARY EMBOLISM 8 0.0001
766 COMA 4 0.0001
767 HYPOGLYCAEMIA 4 0.0001
768 ADRENAL INSUFFICIENCY 1 0.0001
769 HYPERGLYCAEMIA 3 0.0001
770 ILL-DEFINED DISORDER 5 0.0001
771 PRESYNCOPE 2 0.0001
772 PLEURAL EFFUSION 5 0.0001
773 ACCIDENTAL OVERDOSE 3 0.0001
774 DISCOMFORT 5 0.0001
775 CEREBRAL INFARCTION 2 0.0001
776 MUSCLE SPASMS 15 0.0001
777 DYSURIA 3 0.0001
778 LIVER INJURY 2 0.0001
779 MUSCLE SPASTICITY 1 0.0001
780 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
781 CARDIOMEGALY 1 0.0001
782 GENERALISED OEDEMA 1 0.0001
783 HEART RATE INCREASED 8 0.0001
784 DYSARTHRIA 3 0.0001
785 DERMATITIS ALLERGIC 1 0.0001
786 GASTRIC CANCER 2 0.0001
787 MUSCLE ATROPHY 1 0.0001
788 COUGH 22 0.0001
789 HYPOPHAGIA 2 0.0001
790 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
791 PRURITUS 30 0.0001
792 HIATUS HERNIA 1 0.0001
793 DIPLOPIA 2 0.0001
794 DEAFNESS 2 0.0001
795 FEBRILE NEUTROPENIA 5 0.0001
796 EYE HAEMORRHAGE 1 0.0001
797 BLINDNESS 3 0.0001
798 CORONARY ARTERY OCCLUSION 1 0.0001
799 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
800 ASTHMA 8 0.0001
801 DIALYSIS 1 0.0001
802 CARDIOGENIC SHOCK 1 0.0001
803 ACCIDENTAL UNDERDOSE 1 0.0001
804 PANCREATIC CARCINOMA 2 0.0001
805 ASTHENIA 26 0.0001
806 HYPERTHYROIDISM 1 0.0001
807 LIVER FUNCTION TEST ABNORMAL 2 0.0001
808 CHEST DISCOMFORT 7 0.0001
809 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
810 HOT FLUSH 5 0.0001
811 APHASIA 2 0.0001
812 DRUG ADMINISTRATION ERROR 2 0.0001
813 HYPOKALAEMIA 3 0.0001
814 OROPHARYNGEAL PAIN 6 0.0001
815 ANKLE FRACTURE 1 0.0001
816 MENINGIOMA 1 0.0001
817 DYSPHAGIA 6 0.0001
818 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
819 RASH ERYTHEMATOUS 3 0.0001
820 ABSCESS 1 0.0001
821 HIP FRACTURE 2 0.0001
822 CHOLELITHIASIS 2 0.0001
823 MULTIPLE FRACTURES 1 0.0001
824 MANIA 1 0.0001
825 DRUG LEVEL INCREASED 1 0.0001
826 INFUSION RELATED REACTION 4 0.0001
827 SOMNOLENCE 12 0.0001
828 RENAL IMPAIRMENT 5 0.0001
829 HEMIPARESIS 1 0.0001
830 MUSCULOSKELETAL DISCOMFORT 1 0.0001
831 EMOTIONAL DISTRESS 7 0.0001
832 PYREXIA 20 0.0001
833 HAEMORRHAGE 6 0.0001
834 NEUROTOXICITY 1 0.0001
835 METASTASES TO LIVER 1 0.0001
836 AGRANULOCYTOSIS 1 0.0001
837 TOXICITY TO VARIOUS AGENTS 9 0.0001
838 BLOOD SODIUM DECREASED 1 0.0001
839 URINARY TRACT INFECTION 9 0.0001
840 COLITIS 2 0.0001
841 FOOT FRACTURE 1 0.0001
842 GASTRIC ULCER 1 0.0001
843 NEUROPATHY PERIPHERAL 5 0.0001
844 MUSCULOSKELETAL DISORDER 1 0.0001
845 LETHARGY 3 0.0001
846 DRUG PRESCRIBING ERROR 1 0.0001
847 HERNIA 1 0.0001
848 EAR PAIN 1 0.0001
849 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
850 ABORTION SPONTANEOUS 2 0.0000
851 CARDIAC FAILURE CONGESTIVE 4 0.0000
852 THERAPEUTIC RESPONSE DECREASED 3 0.0000
853 NEUTROPHIL COUNT DECREASED 2 0.0000
854 TREMOR 8 0.0000
855 PAIN IN EXTREMITY 14 0.0000
856 OSTEOARTHRITIS 2 0.0000
857 RENAL FAILURE ACUTE 2 0.0000
858 HYPOAESTHESIA 7 0.0000
859 RECTAL HAEMORRHAGE 2 0.0000
860 BALANCE DISORDER 4 0.0000
861 MENTAL DISORDER 2 0.0000
862 BLOOD CREATININE INCREASED 3 0.0000
863 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
864 MELAENA 1 0.0000
865 CHROMATURIA 1 0.0000
866 HEPATIC ENZYME INCREASED 3 0.0000
867 COGNITIVE DISORDER 2 0.0000
868 CHILLS 5 0.0000
869 VOMITING 20 0.0000
870 DISEASE PROGRESSION 5 0.0000
871 ANXIETY 12 0.0000
872 OCULAR HYPERAEMIA 2 0.0000
873 BLOOD PRESSURE FLUCTUATION 1 0.0000
874 INTERSTITIAL LUNG DISEASE 2 0.0000
875 LUNG DISORDER 2 0.0000
876 INJECTION SITE URTICARIA 1 0.0000
877 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
878 ABDOMINAL PAIN LOWER 1 0.0000
879 HAEMOGLOBIN DECREASED 4 0.0000
880 ERECTILE DYSFUNCTION 1 0.0000
881 EXPOSURE VIA SKIN CONTACT 1 0.0000
882 ABDOMINAL DISTENSION 4 0.0000
883 ECZEMA 2 0.0000
884 ANHEDONIA 1 0.0000
885 EAR INFECTION 1 0.0000
886 CARDIAC FAILURE 3 0.0000
887 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
888 FEAR 1 0.0000
889 JAUNDICE 1 0.0000
890 DRUG EFFECT DECREASED 2 0.0000
891 PNEUMONIA 12 0.0000
892 BLOOD BILIRUBIN INCREASED 1 0.0000
893 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
894 LIMB INJURY 1 0.0000
895 HAEMATOCHEZIA 2 0.0000
896 HYPONATRAEMIA 2 0.0000
897 EYE PAIN 2 0.0000
898 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
899 ANGINA PECTORIS 1 0.0000
900 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
901 MALAISE 15 0.0000
902 ASCITES 1 0.0000
903 CORONARY ARTERY DISEASE 1 0.0000
904 INJECTION SITE RASH 1 0.0000
905 PERIPHERAL SWELLING 5 0.0000
906 CARDIAC DISORDER 3 0.0000
907 SWELLING 3 0.0000
908 MOOD SWINGS 1 0.0000
909 HYPOTHYROIDISM 1 0.0000
910 INTENTIONAL OVERDOSE 2 0.0000
911 DEEP VEIN THROMBOSIS 2 0.0000
912 DYSPEPSIA 3 0.0000
913 EYE DISORDER 1 0.0000
914 ABDOMINAL PAIN 7 0.0000
915 FUNGAL INFECTION 1 0.0000
916 ANGER 1 0.0000
917 MYALGIA 5 0.0000
918 PAIN 18 0.0000
919 HAEMATURIA 1 0.0000
920 NIGHTMARE 1 0.0000
921 NEOPLASM PROGRESSION 1 0.0000
922 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
923 DEATH 24 0.0000
924 MOBILITY DECREASED 2 0.0000
925 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
926 HALLUCINATION 2 0.0000
927 BLOOD GLUCOSE INCREASED 5 0.0000
928 NAUSEA 21 0.0000
929 INTESTINAL OBSTRUCTION 1 0.0000
930 ARTHRALGIA 11 0.0000
931 DIARRHOEA 17 0.0000
932 CONDITION AGGRAVATED 8 0.0000
933 INSOMNIA 7 0.0000
934 ANAEMIA 5 0.0000
935 INJECTION SITE SWELLING 2 0.0000
936 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
937 ABNORMAL BEHAVIOUR 1 0.0000
938 FEELING ABNORMAL 6 0.0000
939 THROMBOSIS 2 0.0000
940 ABDOMINAL DISCOMFORT 4 0.0000
941 CONSTIPATION 5 0.0000
942 COVID-19 4 0.0000
943 LIVER DISORDER 1 0.0000
944 COLITIS ULCERATIVE 1 0.0000
945 ADVERSE DRUG REACTION 2 0.0000
946 MEMORY IMPAIRMENT 3 0.0000
947 BLOOD CHOLESTEROL INCREASED 1 0.0000
948 DISEASE RECURRENCE 1 0.0000
949 COLORECTAL CANCER 1 0.0000
950 BLOOD GLUCOSE DECREASED 1 0.0000
951 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
952 HEADACHE 13 0.0000
953 INFECTION 3 0.0000
954 DRY EYE 1 0.0000
955 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
956 INFLAMMATION 1 0.0000
957 PLATELET COUNT DECREASED 2 0.0000
958 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
959 MEDICATION ERROR 1 0.0000
960 NECK PAIN 1 0.0000
961 THROMBOCYTOPENIA 2 0.0000
962 FLATULENCE 1 0.0000
963 CONVULSION 1 0.0000
964 BACK PAIN 4 0.0000
965 PALPITATIONS 2 0.0000
966 NASAL CONGESTION 1 0.0000
967 IRRITABILITY 1 0.0000
968 FEELING HOT 1 0.0000
969 CHEST PAIN 3 0.0000
970 VISUAL IMPAIRMENT 2 0.0000
971 ABDOMINAL PAIN UPPER 3 0.0000
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
973 DIZZINESS 7 0.0000
974 DYSGEUSIA 1 0.0000
975 HOSPITALISATION 2 0.0000
976 DECREASED APPETITE 3 0.0000
977 FALL 4 0.0000
978 DRUG ABUSE 1 0.0000
979 CEREBROVASCULAR ACCIDENT 2 0.0000
980 MYOCARDIAL INFARCTION 2 0.0000
981 DRUG WITHDRAWAL SYNDROME 1 0.0000
982 GASTROINTESTINAL DISORDER 1 0.0000
983 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
984 BREAST CANCER 1 0.0000
985 MIGRAINE 1 0.0000
986 GAIT DISTURBANCE 2 0.0000
987 ILLNESS 1 0.0000
988 DEPRESSION 2 0.0000
989 WEIGHT DECREASED 2 0.0000
990 FATIGUE 5 0.0000
991 DRUG DEPENDENCE 1 0.0000
992 NASOPHARYNGITIS 1 0.0000
993 ALOPECIA 1 0.0000